Cargando…

Empagliflozin in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Purpose: The purpose of the study is to evaluate the effect of empagliflozin in patients with heart failure (HF). Method: We performed a systematic search of PubMed, EMBASE, and the Cochrane Library database through January 20, 2021. Randomized controlled trials (RCTs) were included that compared em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Deng, Xu, Lin, Chen, Pengfei, Jiang, Huiping, Shi, Dazhuo, Guo, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257947/ https://www.ncbi.nlm.nih.gov/pubmed/34239906 http://dx.doi.org/10.3389/fcvm.2021.683281

Ejemplares similares

Serum Uric Acid and Risk of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Miao, Lina, et al.
Publicado: (2021)

Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis
por: Shi, Zepeng, et al.
Publicado: (2022)

Cost-effectiveness of empagliflozin for the treatment of heart failure with reduced ejection fraction in China
por: Sang, Haiqiang, et al.
Publicado: (2022)

Effects of sacubitril/valsartan on life quality in chronic heart failure: A systematic review and meta-analysis of randomized controlled trials
por: Song, Yinyin, et al.
Publicado: (2022)

Knowledge domain and emerging trends in empagliflozin for heart failure: A bibliometric and visualized analysis
por: Zhang, Xuesong, et al.
Publicado: (2022)

Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials
por: Huang, Pingping, et al.
Publicado: (2022)

P2y(12) inhibitor monotherapy after 1–3 months dual antiplatelet therapy in patients with coronary artery disease and chronic kidney disease undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials
por: Yu, Yanqiao, et al.
Publicado: (2023)

Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China
por: Jiang, Yaohui, et al.
Publicado: (2022)

Corrigendum: Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China
por: Jiang, Yaohui, et al.
Publicado: (2023)

The Prognostic Value of Reticulated Platelets in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Zhao, Yihan, et al.
Publicado: (2020)

Estimated Glomerular Filtration Rate Is Associated With an Increased Risk of Death in Heart Failure Patients With Preserved Ejection Fraction
por: Chen, Zhuo, et al.
Publicado: (2021)

Effects of empagliflozin on cardiac structure, function and biomarkers in patients with heart failure with preserved ejection fraction: study protocol for a randomised, placebo-controlled prospective trial
por: Chai, Ke, et al.
Publicado: (2023)

Effects of Microbiota-Driven Therapy on Circulating Trimethylamine-N-Oxide Metabolism: A Systematic Review and Meta-Analysis
por: Miao, Lina, et al.
Publicado: (2021)

Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhou, Hufang, et al.
Publicado: (2022)

Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region
por: Liao, Chia-Te, et al.
Publicado: (2021)

Traditional Chinese medicine injections for heart failure: a protocol for systematic review and network meta-analysis of randomised controlled trials
por: Lin, Shanshan, et al.
Publicado: (2020)

Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials
por: Yu, Wanqian, et al.
Publicado: (2022)

Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials
por: Guo, Hongxin, et al.
Publicado: (2023)

The Prevalence of Activities of Daily Living Impairment in Patients With Heart Failure: A Systematic Review and Meta-Analysis
por: Lu, Jing, et al.
Publicado: (2022)

Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials
por: Zhao, Jin-Dong, et al.
Publicado: (2018)

Effect of Uric Acid-Lowering Agents on Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Xu, Hongxuan, et al.
Publicado: (2021)

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2023)

The microRNA Expression Profiling in Heart Failure: A Systematic Review and Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2022)

Inspiratory muscle training in patients with heart failure: A systematic review and meta-analysis
por: Li, Hui, et al.
Publicado: (2022)

Prognostic significance of delirium in patients with heart failure: a systematic review and meta-analysis
por: Niu, Ziru, et al.
Publicado: (2023)

Catheter ablation vs. drug therapy in the treatment of atrial fibrillation patients with heart failure: An update meta-analysis for randomized controlled trials
por: Lin, Chun, et al.
Publicado: (2023)

Left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation: A systematic review and meta-analysis
por: Chen, Pengfei, et al.
Publicado: (2022)

Effect of Sodium-Glucose Co-transporter Protein 2 Inhibitors on Arrhythmia in Heart Failure Patients With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Yin, Ziwei, et al.
Publicado: (2022)

The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis
por: Yang, Juntao, et al.
Publicado: (2023)

Comparing Machine Learning Models and Statistical Models for Predicting Heart Failure Events: A Systematic Review and Meta-Analysis
por: Sun, Zhoujian, et al.
Publicado: (2022)

Effect of sacubitril/valsartan on the occurrence of cardiac arrhythmias and the risk of sudden cardiac death in heart failure: A meta-analysis of randomized controlled trials
por: Liu, Xue-Hui, et al.
Publicado: (2022)

Albuminuria and Dipstick Proteinuria for Predicting Mortality in Heart Failure: A Systematic Review and Meta-Analysis
por: Liang, Wei, et al.
Publicado: (2021)

Efficacy and safety of Puerarin injection on acute heart failure: A systematic review and meta-analysis
por: Li, Zunjiang, et al.
Publicado: (2022)

Prognostic Value of Left Atrial Strain in Heart Failure: A Systematic Review and Meta-Analysis
por: Jia, Fuwei, et al.
Publicado: (2022)

Predictive value of blood urea nitrogen in heart failure: a systematic review and meta-analysis
por: Duan, Siyu, et al.
Publicado: (2023)

Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials
por: Gong, Bojun, et al.
Publicado: (2016)

Lung ultrasound-guided treatment for heart failure: An updated meta-analysis and trial sequential analysis
por: Li, Yan, et al.
Publicado: (2022)

Feasibility and Preliminary Effects of the BESMILE-HF Program on Chronic Heart Failure Patients: A Pilot Randomized Controlled Trial
por: Chen, Xiankun, et al.
Publicado: (2021)

A Machine Learning-Based Prediction Model for Acute Kidney Injury in Patients With Congestive Heart Failure
por: Peng, Xi, et al.
Publicado: (2022)

The pathophysiology of cognitive impairment in individuals with heart failure: a systematic review
por: Ni, Reine Sam Shi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3e1d9344al48l7bkmk3v4dsmrc